Natural history of hepatic fibrosis progression in chronic hepatitis C virus infection in India

Journal of Gastroenterology and Hepatology (Australia)

Volumn 24, Issue 4, 2009, Pages 581-587

  Hissar, Syed S ^b   Kumar, Manoj ^b   Tyagi, Pankaj ^b   Goyal, Ankur ^b   Pv, Suneetha ^b   Agarwal, Sriram ^b   Rastogi, Archana ^b   Sakhuja, Puja ^b   Sarin, Shiv K ^a,b  

^a UNIVERSITY OF DELHI   (India)

^b G B PANT HOSPITAL   (India)

Author keywords

Chronic hepatitis C; Duration; Fibrosis; Genotype; Hepatitis C virus; Progression rate

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; DISEASE TRANSMISSION; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HISTOLOGY; HUMAN; HUMAN TISSUE; INDIA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; SEX DIFFERENCE;

EID: 63849293362     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2008.05649.x     Document Type: Article

References (43)

1. Alter MJ. The epidemiology of hepatitis c in the west. Semin. Liver Dis. 1995 15 : 5 14
2. Goswami PN, Patel HA, Patel JS et al. Prevalence of hepatitis C virus: a report from Gujrat Cancer Research Institute. Indian J Gastroenterol. 1999 18 (suppl. S33.
3. Nanu A, Sharma SP, Chatterjee K et al. Markers for transfusion- transmissible infection in North Indian Voluntary and replacement blood donors: prevalence and trends 1989-1996. Vox. Sang. 1997 73 : 70 3.
4. Panigrahi AK, Panda SK, Dixit RK et al. Magnitude of hepatitis C virus infection in India: Prevalence in healthy blood donors, acute and chronic liver diseases. J. Med. Virol. 1997 51 : 167 74.
5. Tong MJ, EI-Farra NS, Reikes AR et al. Clinical outcomes after transfusion-associated hepatitis C. N. Engl. J. Med. 1995 332 : 1463 6.
6. Boccato S, Pistis R, Noventa F, Guido M, Benvegnù L, Alberti A. Fibrosis progression in initially mild chronic hepatitis C. J. Viral. Hepat. 2006 13 : 297 302.
7. Ryder SD,. Progression of hepatic fibrosis in patients with hepatitis C: a prospective repeat liver biopsy study. Gut 2004 53 : 451 5.
8. Poynard T, Ratziu V, Charlotte F, Goodman Z, McHutchison J, Albrecht J. Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C. J. Hepatol. 2001 34 : 730 9.
9. Lagging LM, Westin J, Svensson E et al. Progression of fibrosis in untreated patients with hepatitis C virus infection. Liver 2002 22 : 136 44.
10. Castéra L, Hézode C, Roudot-Thoraval F et al. Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies. Gut 2003 52 : 288 92.
11. Di Bisceglie AM, Goodman ZD, Ishak KG, Hoofnagle JH, Melpoder JJ, Alter H. Long-term clinical and histopathological follow-up of chronic post-transfusion hepatitis. Hepatology 1991 14 : 969 74.
12. Takahashi M, Yamada G, Miyamoto R, Doi T, Endo H, Tsuji T. Natural course of chronic hepatitis C. Am. J. Gastroenterol. 1993 88 : 240 3.
13. Kiyosawa K, Sodeyama T, Tanaka E et al. Interrelationship of blood transfusion, non-A non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibodies to hepatitis C virus. Hepatology 1990 12 : 671 5.
14. Kobayashi M, Tanaka E, Sodeyama T, Urushihara A, Matsumoto A, Kiyosawa K. The natural course of chronic hepatitis C: a comparison between patients with genotypes 1 and 2 hepatitis C viruses. Hepatology 1996 23 : 695 9.
15. Delladetsima JK, Rassidakis G, Tassopoulos NC, Papathodoridis GV, Smymoff T, Vafiadis I. Histopathology of chronic hepatitis C in relation to epidemiological factors. J Hepatol 1996 24 : 27 32.
16. Tremolada F, Casarin C, Alberti A et al. Long-term follow-up of non-A, non-B (type C) post-transfusion hepatitis. J. Hepatol. 1992 16 : 273 81.
17. Yano M, Kumada H, Kage M et al. The long term pathological evolution of chronic hepatitis C. Hepatology 1996 23 : 1334 40.
18. Genesca J, Esteban JI, Alter H. Blood-borne non-A, non-B hepatitis: hepatitis C. Semin. Liver. Dis. 1991 11 : 147 64.
19. Poynard T, Bedossa P, Opolon P,. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997 349 : 825 32.
20. Amarapurkar D. Natural history of hepatitis C virus infection. J. Gastroenterol. Hepatol. 2000 15 (suppl. E105 E110.
21. Minola E, Prati D, Suter F et al. Age at infection affects the long-term outcome of transfusion-associated chronic hepatitis C. Blood 2002 99 : 4588 91.
22. Ghany MG, Kleiner DE, Alter H et al. Progression of fibrosis in chronic hepatitis C. Gastroenterology 2003 124 : 97 104.
23. Wilson LE, Torbenson M, Astemborski J et al. Progression of Liver fibrosis among injection drug users with chronic hepatitis C. Hepatology 2006 43 : 788 95.
24. Cha TA, Kolberg J, Irvine B et al. Use of a signature nucleotide sequence of hepatitis C virus for detection of viral RNA in human serum and plasma. J. Clin. Microbiol. 1991 29 : 2528 34.
25. Stuyver L, Rossau R, Wyseur A et al. Typing of hepatitis C virus isolates and characterization of new subtype using a line probe assay. J. Gen Virol 1993 74 : 1093 102.
26. Knodell RG, Ishak KG, Black WC et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981 1 : 431 5.
27. Fattovich G, Giustina G, Degos F et al. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology 1997 112 : 463 72.
28. Bucher NL. Regeneration of mammalian liver. In : Bourne GH, Danielli JF, eds. Review of Cytology, vol 15. London : Academic Press, 1963 246 97.
29. Van Thiel DH, Stauber R, Gavaler JS, Francavilla A. Hepatic regeneration; effects of age, sex, hormone status, prolactin and cyclosporine. Dig. Dis. Sci. 1991 36 : 1309 12.
30. Crowe J, Doyle C, Fielding HF et al. Presentation of hepatitis C in a unique uniform cohort 17 years from inoculation. Gastroenterology 1995 108 : 1054A.
31. Dittmann S, Roggendorf M, Durkop J, Wiese M, Lorbeer B, Deinhardt F. Long-term persistence of hepatitis virus antibodies in a single source outbreak. J. Hepatol. 1991 13 : 323 7.
32. Yamakawa Y, Sata M, Suzuki H, Noguchi S, Tanikawa K. Higher elimination rate of hepatitis C virus among women. J. Viral. Hepat. 1996 3 : 317 21.
33. DuBois DB, Gretch D, dela Rosa C et al. Quantitation of hepatitis C viral RNA in sera of hemodialysis patients: gender related differences in viral load. Am. J. Kidney Dis. 1994 24 : 795 801.
34. Yasuda M, Shimizu I, Shiba M, Ito S. Suppressive effects of estradiol on dimethylnitrosamine induced fibrosis of liver in rats. Hepatology 1999 29 : 719 27.
35. Dusheiko G, Weiss HS, Brown D et al. Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease. Hepatology 1994 19 : 13 8.
36. Ichimura H, Tamura I, Kurimura O et al. Hepatitis C virus genotypes, reactivity to recombinant immunoblot assay 2 antigens and liver disease. J. Med. Virol. 1994 43 : 212 5.
37. Pozzatto G, Morretti M, Franzin F et al. Severity of liver disease with different hepatitis C viral clones (Letter). Lancet 1991 338 : 509.
38. Matsumura H, Moriyama M, Goto I, Tanaka N, Okubo H, Arakawa Y. Natural course of progression of liver fibrosis in Japanese patients with chronic liver disease type C - a study of 527 patients at one establishment. J. Viral. Hepat. 2000 7 : 268 75.
39. Seef LB. Natural history of hepatitis C. Hepatology 1997 26 (suppl 1 21S 28S.
40. Weltman MD, Brotodihardjo A, Crewe EB et al. Coinfection with hepatitis B and C or B, C and delta viruses results in severe chronic liver disease and responds poorly to interferon- alpha treatment. J. Viral. Hepat. 1995 2 : 39 45.
41. Shiratori Y, Shiina S, Zhang PY et al. Does dual infection by hepatitis B and C viruses play an important role in the pathogenesis of hepatocellular carcinoma in Japan?. Cancer 1997 80 : 2060 7.
42. Fong TL, DI Bisceglie AM, Waggoner JG, Banks SM, Hoofnagle JH. The significance of antibody to hepatitis C virus in patients with chronic hepatitis B. Hepatology 1991 14 : 64 7.
43. Chiba T, Matsuzaki Y, Abei M et al. The role of previous hepatitis B virus infection and heavy smoking in hepatitis C virus-related hepatocellular carcinoma. Am. J. Gastroenterol. 1996 91 : 199 203.